These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12953952)

  • 1. Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis.
    Lanbeck P; Odenholt I; Paulsen O
    Scand J Infect Dis; 2003; 35(6-7):397-400. PubMed ID: 12953952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study.
    Lanbeck P; Odenholt I; Paulsen O
    Scand J Infect Dis; 2002; 34(7):512-9. PubMed ID: 12195877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endothelial damage caused by the semisynthetic penicillins cloxacillin dicloxacillin and flucloxacillin].
    Sinapius D; Bründel KH
    Vasa; 1975; 4(1):54-8. PubMed ID: 1189592
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver damage from flucloxacillin, cloxacillin and dicloxacillin.
    Olsson R; Wiholm BE; Sand C; Zettergren L; Hultcrantz R; Myrhed M
    J Hepatol; 1992 May; 15(1-2):154-61. PubMed ID: 1506634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis.
    Lanbeck P; Odenholt I; Riesbeck K
    J Antimicrob Chemother; 2004 Feb; 53(2):174-9. PubMed ID: 14729754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phlebitis risk varies by peripheral venous catheter site and increases after 96 hours: a large multi-centre prospective study.
    Cicolini G; Manzoli L; Simonetti V; Flacco ME; Comparcini D; Capasso L; Di Baldassarre A; Eltaji Elfarouki G
    J Adv Nurs; 2014 Nov; 70(11):2539-49. PubMed ID: 24684163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial.
    Maki DG; Ringer M
    Ann Intern Med; 1991 May; 114(10):845-54. PubMed ID: 2014945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors and medical cost of peripheral intravenous catheter-related complications in hospitalised adult patients.
    Liu C; Chen L; Kong D; Lyu F; Luan L; Yang L
    J Vasc Access; 2022 Jan; 23(1):57-66. PubMed ID: 33302797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin.
    Marcy SM; Klein JO
    Med Clin North Am; 1970 Sep; 54(5):1127-43. PubMed ID: 4919148
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neurotoxicity of penicillins].
    Melby K
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):175. PubMed ID: 7385145
    [No Abstract]   [Full Text] [Related]  

  • 11. The incidence and risk of infusion phlebitis with peripheral intravenous catheters: A meta-analysis.
    Lv L; Zhang J
    J Vasc Access; 2020 May; 21(3):342-349. PubMed ID: 31547791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity in isoxazolylpenicillin prophylaxis in hip surgery.
    Hedström SA; Hybbinette CH
    Acta Orthop Scand; 1988 Apr; 59(2):144-7. PubMed ID: 3129901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phlebitis induced by parenteral treatment with flucloxacillin and cloxacillin: a double-blind study.
    Svedhem A; Alestig K; Jertborn M
    Antimicrob Agents Chemother; 1980 Aug; 18(2):349-52. PubMed ID: 7447412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function after hip arthroplasty and isoxazolylpenicillin prophylaxis.
    Wahlström O; Maller R; Djerf K; Ivarsson I
    Acta Orthop Scand; 1992 Oct; 63(5):539-42. PubMed ID: 1441952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral Venous Catheter-Related Adverse Events: Evaluation from a Multicentre Epidemiological Study in France (the CATHEVAL Project).
    Miliani K; Taravella R; Thillard D; Chauvin V; Martin E; Edouard S; Astagneau P;
    PLoS One; 2017; 12(1):e0168637. PubMed ID: 28045921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of Phlebitis: A Systematic Review and Meta-analysis.
    Chang WP; Peng YX
    Nurs Res; 2018; 67(3):252-260. PubMed ID: 29698331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the influence of risk factors on rates and dynamics of peripheral vein phlebitis: an observational cohort study.
    Mestre Roca G; Berbel Bertolo C; Tortajada Lopez P; Gallemi Samaranch G; Aguilar Ramirez MC; Caylà Buqueras J; Rodríguez-Baño J; Martinez JA
    Med Clin (Barc); 2012 Jul; 139(5):185-91. PubMed ID: 22538061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors of phlebitis associated to peripheral intravenous catheters.
    Arias-Fernández L; Suérez-Mier B; Martínez-Ortega MD; Lana A
    Enferm Clin; 2017; 27(2):79-86. PubMed ID: 27640931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation.
    Cornely OA; Bethe U; Pauls R; Waldschmidt D
    Infect Control Hosp Epidemiol; 2002 May; 23(5):249-53. PubMed ID: 12026149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.
    Sutherland R; Croydon EA; Rolinson GN
    Br Med J; 1970 Nov; 4(5733):455-60. PubMed ID: 5481218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.